Presentation is loading. Please wait.

Presentation is loading. Please wait.

Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.

Similar presentations


Presentation on theme: "Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The."— Presentation transcript:

1 Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The contents of the presentation may be modified, but the Psychopharmacology Institute logo must remain visible in all slides.

2 What is an Opioid Use Disorder?
Joji Suzuki, MD Director, Division of Addiction Psychiatry Department of Psychiatry, Brigham and Women’s Hospital Assistant Professor of Psychiatry, Harvard Medical School

3 Outline Opiates vs opioids
Papaver Somniferum and the beginning of pharmaceutical opioid formulations Heroin: First tried as substitution treatment Opioid of choice in 70’s and 80’s Preparation and routes of administration

4 Outline Opiates vs opioids
Papaver Somniferum and the beginning of pharmaceutical opioid formulations Heroin: First tried as substitution treatment Opioid of choice in 70’s and 80’s Preparation and routes of administration

5 Outline Opiates vs opioids
Papaver Somniferum and the beginning of pharmaceutical opioid formulations Heroin: First tried as substitution treatment Opioid of choice in the 70’s and 80’s Preparation and routes of administration

6 Outline Opiates vs opioids
Papaver Somniferum and the beginning of pharmaceutical opioid formulations Heroin: First tried as substitution treatment Opioid of choice in the 70’s and 80’s Preparation and routes of administration

7 Nomenclature: Opiates vs Opioids

8 Compounds that activate opioid receptors
Opioids: Compounds that activate opioid receptors Opiates: Compounds derived from Papaver Somniferum Morphine Codeine

9 Compounds that activate opioid receptors
Opioids: Compounds that activate opioid receptors Opiates: Compounds derived from Papaver Somniferum Morphine Codeine

10 Semisynthetic opioids
Heroin (diacetylmorphine) Oxycodone Hydromorphone Buprenorphine Naloxone Hydrocodone Naltrexone

11 Semisynthetic opioids
Heroin (diacetylmorphine) Oxycodone Hydromorphone Buprenorphine Naloxone Hydrocodone Naltrexone Structurally related to morphine and codeine Cross reaction with morphine urine tests

12 Synthetic opioids Meperidine Methadone Fentanyl
Negative on morphine tests Not structurally related to morphine and codeine

13 Naturally occurring opioids
Endorphins Salvinorin A (hallucinogenic mint-family plant)

14 Analgesia Euphoria Cough suppression Constricted pupils Constipation Sedation Respiratory depression Hormonal changes Nausea Mu receptors Dysphoria Hallucinations Kappa receptors Convulsant Delta receptors

15 Analgesia Euphoria Cough suppression Constricted pupils Constipation Sedation Respiratory depression Hormonal changes Nausea Mu receptors Dysphoria Hallucinations Kappa receptors Convulsant Delta receptors

16 Analgesia Euphoria Cough suppression Constricted pupils Constipation Sedation Respiratory depression Hormonal changes Nausea Mu receptors Dysphoria Hallucinations Kappa receptors Convulsant Delta receptors

17 Next: From P. Somniferum to Heroin


Download ppt "Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The."

Similar presentations


Ads by Google